Form 4: BridgeBio CFO Sells Shares for Tax Obligation
Insider Transaction Report
BridgeBio Pharma's President and CFO, Thomas Trimarchi, disposed of 13,826 shares of common stock to cover tax obligations related to RSU vesting.
Summary
- Thomas Trimarchi, President and CFO of BridgeBio Pharma, Inc. (BBIO), reported a disposition of common stock.
- On December 12, 2025, Trimarchi disposed of 13,826 shares of BBIO common stock at a price of $75.15 per share.
- This transaction was conducted to satisfy tax obligations associated with the vesting of 25,000 Restricted Stock Units (RSUs).
- Following this transaction, Trimarchi directly beneficially owns 369,004 shares of BridgeBio Pharma, Inc. common stock.
Sentiment
Score: 5
Explanation: The filing reports a routine insider transaction for tax withholding purposes, which is a neutral event and does not indicate positive or negative sentiment regarding the company's performance or outlook.
Future Outlook
This filing does not contain any forward-looking statements or guidance.
Industry Context
This is a routine insider transaction related to compensation and tax obligations, which is common across all industries for executives receiving equity-based compensation.
Stakeholder Impact
- Shareholders: Minimal impact as this is a routine, non-discretionary transaction for tax purposes related to executive compensation.
Key Dates
| Date | Description |
|---|---|
| 12/12/2025 | Date of transaction where common stock was disposed of for tax withholding. |
| 12/16/2025 | Date the Form 4 was signed by the attorney-in-fact. |
Keywords
BridgeBio Pharma, BBIO, Form 4, Insider Transaction, Stock Sale, Tax Withholding, RSU Vesting, Thomas Trimarchi
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.